Dr. Tina Young Poussaint, MD

• Diagnostic Radiology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Yale-new Haven Hospital

  Internship Hospital, 1989

• Massachusetts General Hospital

  Fellowship Hospital, 1989

• Massachusetts General Hospital

  Residency Hospital, 1987

• Yale New Haven Hospital

  Internship Hospital, 1984

• Yale New Haven Hospital|yale-new Haven Hospital

  Internship Hospital, 1984

• Tale University School Of Medicine

  Medical School, 1983

• Tale University School Of Medicine|yale University School Of Medicine

  Medical School, 1983

• Yale School Of Medicine

  Medical School, 1983

• Mount Holyoke College

  Undergraduate School, 1979

• NCI Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury, 2018-05-01

• Pediatric Brain Tumor Consortium Multi-site Assessment of Apparent Diffusion Coefficient z-Axis Variation Assessed with an Ice Water Phantom, 2014-11-27

• Challenges With Defining Response to Antitumor Agents in Pediatric Neuro-Oncology: A Report From the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group, 2013-04-26

• A phase I trial of the CDK 4/6 inhibitor palbociclibin pediatric patients with progressive braintumors: a Pediatric Brain Tumor Consortium study (PBTC-042), 2021-01-06

• 18F-FDG PET and MR Imaging Associations Across a Spectrum of Pediatric Brain Tumors: A Report from the Pediatric Brain Tumor Consortium, 2014-07-28

• Magnetic resonance volumetric assessments of brains in fetuses with ventriculomegaly correlated to outcome, 2013-06-03

• Quantifying Radiation Therapy Response using Apparent Diffusion Coefficient (ADC) Parametric Mapping of Pediatric Diffuse Intrinsic Pontine Glioma: A report from the Pediatric Brain Tumor Consortium, 2019-02-27

• Exploratory Evaluation of MR Permeability with18F-FDG PET Mapping in Pediatric Brain Tumors: A Report from the Pediatric Brain Tumor Consortium, 2013-06-25

• A molecular biology and phase ii study of imetelstat (grn163l) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study, 2016-06-27

• Magnetic Resonance Imaging-based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma, 2018-12-06

• Evaluation of18F-FDG PET and MRI Associations in Pediatric Diffuse Intrinsic Brain stem Glioma: A Report from the Pediatric Brain Tumor Consortium, 2011-01-13

• A Pediatric Brain Tumor Consortium Phase II Trial of Capecitabine Rapidly Disintegrating Tablets with Concomitant Radiation Therapy in Children with Newly Diagnosed Diffuse Intrinsic Pontine Gliomas, 2017-11-01

• A Phase I trial and PK Study of Cediranib (AZD2171), an Orally Bioavailable Pan-VEGFR Inhibitor, in Children with Recurrent or Refractory Primary CNS Tumors, 2015-07-19

• Phase I Study of SU5416, a Small Molecule Inhibitor of the Vascular Endothelial Growth Factor Receptor (VEGFR) in Refractory Pediatric Central Nervous System Tumors, 2009-10-30

• Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020 Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or MIS-C, 2022-11-07

• Establishment and Results of a Magnetic Resonance Quality Assurance Program for the Pediatric Brain Tumor Consortium, 2008-09-06

• Multisystem Inflammatory-like Syndrome in a Child Following COVID-19 mRNA Vaccination, 2021-12-30

• Neurological and Psychological Sequelae Associated With Multisystem Inflammatory Syndrome in Children Neurological and Psychological Sequelae of Multisystem Inflammatory Syndrome in Children, 2023-07-19

• Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0, 2022-05-10